CLINICAL ROLE -
Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?
Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.
A New Direction in Reversal
Target-specific oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban are now being used in a larger and more diverse patient population.
Target-Specific Oral Anticoagulants for Treating Venous Thromboembolism
The new target-specific oral anticoagulants, which include dabigatran, rivaroxaban, apixaban, and edoxaban have demonstrated safety and efficacy in the treatment of venous thromboembolism.
Recurrent Cancer-Associated Thrombosis
Neuraxial Anesthesia and Anticoagulation
Inflammatory Bowel Disease: Focus on Venous Thromboembolism
Contraception Choices for Women at Risk for Venous Thromboembolism
Warfarin-Induced Skin Necrosis
A review of skin necrosis, a rare but devastating adverse effect associated with warfarin use.
Heparin Allergy: Get "HIT" with the Facts
Heparin-induced thrombocytopenia (HIT) is a well-described adverse drug reaction that can occur with heparin administration and lead to devastating thromboembolic complications.
Patient-Centered Care: Warfarin Nonadherence in Patients with Mental Health Conditions
The influence of mental illness on adherence among patients who should be taking warfarin is not well understood.
APS: More than Just a Thrombophilia
2 Clarke Drive Cranbury, NJ 08512